FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2120353337> ?p ?o ?g. }

• W2120353337 endingPage "912" @default.
• W2120353337 startingPage "908" @default.
• W2120353337 abstract "PurposeTo prospectively determine the distribution, extent, and age of venous thrombosis in patients presenting with acute signs and symptoms of venous thromboembolism and identify candidates for thrombolysis.Materials and MethodsFive hundred seventy-six consecutive patients (281 male, 295 female; mean age 58) referred for lower extremity deep vein thrombosis (DVT) assessment between November 2007 and April 2008 were included in the study. Documented cases of DVT were categorized by age (acute, chronic, and acute on chronic), anatomic location, and extent. Patients with iliofemoral and femoropopliteal DVT were evaluated for thrombolysis using standard criteria.ResultsDVT was found in 19% of patients (112/576). Of these, 31 patients (27.7%, 31/112) had isolated calf DVT, 61 patients (54.5%, 61/112) had proximal vein thrombosis extending into the femoropopliteal venous segments, and 20 patients (17.9%, 20/112) presented with iliofemoral DVT. Using standard criteria, 12 patients were selected as potential candidates for pharmacomechanical thrombolysis (PhMT). This equated to an incidence of 2% (12/576) in the population studied, 11% of patients (12/112) with DVT, 26.1% of patients (12/46) presenting with acute proximal DVT, and 20% of patients (4/20) with iliofemoral DVT.ConclusionThe incidence of potential candidates for thrombolysis is low. These data should be considered when recruiting centers to participate in ongoing clinical trials assessing the efficacy of these techniques. To prospectively determine the distribution, extent, and age of venous thrombosis in patients presenting with acute signs and symptoms of venous thromboembolism and identify candidates for thrombolysis. Five hundred seventy-six consecutive patients (281 male, 295 female; mean age 58) referred for lower extremity deep vein thrombosis (DVT) assessment between November 2007 and April 2008 were included in the study. Documented cases of DVT were categorized by age (acute, chronic, and acute on chronic), anatomic location, and extent. Patients with iliofemoral and femoropopliteal DVT were evaluated for thrombolysis using standard criteria. DVT was found in 19% of patients (112/576). Of these, 31 patients (27.7%, 31/112) had isolated calf DVT, 61 patients (54.5%, 61/112) had proximal vein thrombosis extending into the femoropopliteal venous segments, and 20 patients (17.9%, 20/112) presented with iliofemoral DVT. Using standard criteria, 12 patients were selected as potential candidates for pharmacomechanical thrombolysis (PhMT). This equated to an incidence of 2% (12/576) in the population studied, 11% of patients (12/112) with DVT, 26.1% of patients (12/46) presenting with acute proximal DVT, and 20% of patients (4/20) with iliofemoral DVT. The incidence of potential candidates for thrombolysis is low. These data should be considered when recruiting centers to participate in ongoing clinical trials assessing the efficacy of these techniques." @default.
• W2120353337 created "2016-06-24" @default.
• W2120353337 creator A5003268346 @default.
• W2120353337 creator A5008729324 @default.
• W2120353337 creator A5025037742 @default.
• W2120353337 creator A5027160775 @default.
• W2120353337 creator A5066498541 @default.
• W2120353337 date "2010-04-01" @default.
• W2120353337 modified "2023-09-23" @default.
• W2120353337 title "Prospective determination of candidates for thrombolysis in patients with acute proximal deep vein thrombosis" @default.
• W2120353337 cites W1982885425 @default.
• W2120353337 cites W1984232019 @default.
• W2120353337 cites W1991475780 @default.
• W2120353337 cites W1995871977 @default.
• W2120353337 cites W2004667570 @default.
• W2120353337 cites W2005086258 @default.
• W2120353337 cites W2011124785 @default.
• W2120353337 cites W2016609963 @default.
• W2120353337 cites W2020033862 @default.
• W2120353337 cites W2032215337 @default.
• W2120353337 cites W2043976304 @default.
• W2120353337 cites W2049369153 @default.
• W2120353337 cites W2052174005 @default.
• W2120353337 cites W2055625014 @default.
• W2120353337 cites W2066133764 @default.
• W2120353337 cites W2075876711 @default.
• W2120353337 cites W2080409927 @default.
• W2120353337 cites W2100283122 @default.
• W2120353337 cites W2120412915 @default.
• W2120353337 cites W2123614895 @default.
• W2120353337 cites W2155162963 @default.
• W2120353337 cites W2160640646 @default.
• W2120353337 cites W2161541695 @default.
• W2120353337 cites W2167955183 @default.
• W2120353337 doi "https://doi.org/10.1016/j.jvs.2009.11.043" @default.
• W2120353337 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20347687" @default.
• W2120353337 hasPublicationYear "2010" @default.
• W2120353337 type Work @default.
• W2120353337 sameAs 2120353337 @default.
• W2120353337 citedByCount "15" @default.
• W2120353337 countsByYear W21203533372012 @default.
• W2120353337 countsByYear W21203533372013 @default.
• W2120353337 countsByYear W21203533372014 @default.
• W2120353337 countsByYear W21203533372015 @default.
• W2120353337 countsByYear W21203533372016 @default.
• W2120353337 countsByYear W21203533372018 @default.
• W2120353337 countsByYear W21203533372019 @default.
• W2120353337 countsByYear W21203533372020 @default.
• W2120353337 countsByYear W21203533372023 @default.
• W2120353337 crossrefType "journal-article" @default.
• W2120353337 hasAuthorship W2120353337A5003268346 @default.
• W2120353337 hasAuthorship W2120353337A5008729324 @default.
• W2120353337 hasAuthorship W2120353337A5025037742 @default.
• W2120353337 hasAuthorship W2120353337A5027160775 @default.
• W2120353337 hasAuthorship W2120353337A5066498541 @default.
• W2120353337 hasBestOaLocation W21203533371 @default.
• W2120353337 hasConcept C120665830 @default.
• W2120353337 hasConcept C121332964 @default.
• W2120353337 hasConcept C126322002 @default.
• W2120353337 hasConcept C141071460 @default.
• W2120353337 hasConcept C188816634 @default.
• W2120353337 hasConcept C2778959117 @default.
• W2120353337 hasConcept C2779581417 @default.
• W2120353337 hasConcept C2780011451 @default.
• W2120353337 hasConcept C2780868729 @default.
• W2120353337 hasConcept C2908647359 @default.
• W2120353337 hasConcept C500558357 @default.
• W2120353337 hasConcept C61511704 @default.
• W2120353337 hasConcept C71924100 @default.
• W2120353337 hasConcept C99454951 @default.
• W2120353337 hasConceptScore W2120353337C120665830 @default.
• W2120353337 hasConceptScore W2120353337C121332964 @default.
• W2120353337 hasConceptScore W2120353337C126322002 @default.
• W2120353337 hasConceptScore W2120353337C141071460 @default.
• W2120353337 hasConceptScore W2120353337C188816634 @default.
• W2120353337 hasConceptScore W2120353337C2778959117 @default.
• W2120353337 hasConceptScore W2120353337C2779581417 @default.
• W2120353337 hasConceptScore W2120353337C2780011451 @default.
• W2120353337 hasConceptScore W2120353337C2780868729 @default.
• W2120353337 hasConceptScore W2120353337C2908647359 @default.
• W2120353337 hasConceptScore W2120353337C500558357 @default.
• W2120353337 hasConceptScore W2120353337C61511704 @default.
• W2120353337 hasConceptScore W2120353337C71924100 @default.
• W2120353337 hasConceptScore W2120353337C99454951 @default.
• W2120353337 hasIssue "4" @default.
• W2120353337 hasLocation W21203533371 @default.
• W2120353337 hasLocation W21203533372 @default.
• W2120353337 hasOpenAccess W2120353337 @default.
• W2120353337 hasPrimaryLocation W21203533371 @default.
• W2120353337 hasRelatedWork W2007172212 @default.
• W2120353337 hasRelatedWork W2016360538 @default.
• W2120353337 hasRelatedWork W2060887929 @default.
• W2120353337 hasRelatedWork W2357411859 @default.
• W2120353337 hasRelatedWork W2361009766 @default.
• W2120353337 hasRelatedWork W2368737360 @default.
• W2120353337 hasRelatedWork W2390273518 @default.
• W2120353337 hasRelatedWork W2421632477 @default.
• W2120353337 hasRelatedWork W2981730791 @default.

• next